Showing results (71-80 of 129) with videos related to
Sort By:
Pageof 13
Rhode Island Medical Journal (2013)|September 26, 2025
A Rare Genital Concomitant Presentation of Extracavitary Primary Effusion Lymphoma and Squamous Cell CarcinomaKinda Rajab, Yael Tsenter, Adam J Olszewski, et al.Journal of Geriatric Oncology|February 21, 2021
Prevalence of functional limitations and their associations with systemic cancer therapy among older adults in nursing homes with advanced non-small cell lung cancerOrestis A Panagiotou, Tamra Keeney, Jessica A Ogarek, et al.American Journal of Hematology|May 13, 2015
Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER databaseJorge J Castillo, Adam J Olszewski, Sandra Kanan, et al.Cancer|March 12, 2015
Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER databaseJorge J Castillo, Adam J Olszewski, Zachary R Hunter, et al.Rhode Island Medical Journal (2013)|May 27, 2021
Thrombosis in COVID-19: A Narrative Review of Current Literature and Inpatient ManagementAndrew Hsu, Sarah Ohnigian, Augustus Chang, et al.Plos One|February 25, 2017
Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot studyAndrew Schumacher, William M Sikov, Matthew I Quesenberry, et al.Clinical Lymphoma, Myeloma & Leukemia|February 14, 2018
Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual DiseaseThomas A Ollila, Adam J Olszewski, James N Butera, et al.The Oncologist|March 21, 2023
Ixazomib, Oral Metronomic Cyclophosphamide, and Dexamethasone for First-Line Treatment of Multiple Myeloma: A Phase II Brown University Oncology Group StudyAri Pelcovits, Peter Barth, John L Reagan, et al.American Journal of Clinical Oncology|December 10, 2020
Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing RegimensEric I Marks, Robert Matera, Adam J Olszewski, et al.Journal of Gastrointestinal Cancer|December 5, 2012
Phase I study of oxaliplatin in combination with gemcitabine, irinotecan, and 5-fluorouracil/leucovorin (G-FLIE) in patients with metastatic solid tumors including adenocarcinoma of the pancreasAdam J Olszewski, Michael L Grossbard, Michael S Chung, et al.Pageof 13